Market Forecast By Type (Injectable, Tablets), By Route of Administration (Oral, Intravenous), By Dosage (100 MG, 200 MG, 250 MG, 500 MG), By Applications (COVID-19, Rheumatoid Arthritis, Malaria & Others), By Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) and competitive landscape
Product Code: ETC002150 | Publication Date: Apr 2020 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
The global hydroxychloroquine and chloroquine market is forecast to witness substantial growth over the coming years backed by increasing cases of COVID-19 pandemic globally, no specific treatment available for COVID-19 patients, a rising number of worldwide deaths as well as increasing cases of malaria and another autoimmune disease such as lupus erythematosus and rheumatoid arthritis globally. Hydroxychloroquine has created a revolutionary impact globally for the treatment of COVID-19 during in-vivo studies and laboratory testing. The increased use of the pharmaceutical drug for the stoppage and treatment of various forms of malaria such as chloroquine-sensitive malaria, rheumatoid arthritis, malaria, lupus erythematosus, rheumatoid arthritis, and Q fever is making it an ideal treatment drug across the pharmaceutical industry and is expected to leave a positive impact on the market growth of the drug globally in the foreseeable future.
According to 6Wresearch, Global Hydroxychloroquine and Chloroquine Market is projected to grow substantially during 2020-2026. This growth is primarily driven by the increasing import of hydroxychloroquine and chloroquine by major developed countries, for instance, the U.S. and other key European countries such as Spain, Italy, France, and Germany for the treatment of COVID-19. The demand for hydroxychloroquine has skyrocket globally ever since the U.S. government has imported huge quantities of hydroxychloroquine from India. Additionally, several countries such as Brazil, Canada, Bahrain, Seychelles, Mauritius, and the SAARC neighboring countries have also imported hydroxychloroquine from India.
In terms of dosage, the 400 mg dosage vertical accounted for the majority of the market share in the global hydroxychloroquine and chloroquine market. In terms of regions, India is one of the leading producers of hydroxychloroquine and chloroquine globally and several Indian players have increased the production volumes of hydroxychloroquine in order to meet the internal and export demand. Whereas, in terms of type, the tablet form of hydroxychloroquine and chloroquine is dominating the global hydroxychloroquine and chloroquine market.
Some of the key players in the global hydroxychloroquine and chloroquine market are Teva, Torrent Pharma, Mylan, Novartis, Cadila healthcare, BSE healthcare, Shenhua Pharm, Sanofi, H-QYN, TAJ Pharma, Sandoz, HIKMA, IPCA, Shanghai Pharma, MAAN Medex, Cinkate, and Concordia Healthcare.
The spread of COVID-19 has left a positive impact on the deployment of Hydroxychloroquine and Chloroquine in the manufacture of medicines
Hydroxychloroquine is the tablet form that is the medicine authorized by the EU used for the treatment of arthritis and skin diseases and used to prevent form malaria. The medicine is authorized in the context authorities granted for the marketing authorization which going to manufacture the medicine. Further, the drug is being highly in use presently for the cure of the novel coronavirus and is widely in use by many countries at present across the globe. Many hospitals allowed the use of the medicine hydroxychloroquine in the treatment of the COVID-19 patient and hydroxychloroquine is prescribed by the doctors according to the assessment and responsibility. The hydroxychloroquine and chloroquine have a real effect on the treatment of COVID-19. However, the side effects of using the drug for the treatment of COVID-19 are not yet revealed, which has assisted the pharmaceutical industries globally to deploy the drug in the manufacture of COVID-19 treatment medicine.
Chloroquine has been proven evident for the treatment of malaria and amebiasis. The rising number of malaria cases each year across the globe has no doubt created a need for the successful implementation of a vaccine and treatment medicine. Chloroquine has proven itself as a salt for the successful treatment of malaria and is gaining huge popularity in pharmaceuticals. An increase in the deployment of the salt for the making of malaria treating medicine is anticipated to assist the global hydroxychloroquine and chloroquine market gain strong growth potential in the coming time zone and the near future extending up to the year 2027. Further, below mentioned is the list of the countries which register a high number of malaria patients each year and as a result, the rising number of malaria cases in the below-mentioned countries is anticipated to bring in bountiful opportunities for the potential manufacturers to find market growth potential in the coming time zone.
Key Highlights of the Report:
Markets Covered:
The global hydroxychloroquine and chloroquine market report provides a detailed analysis of the following market segments:
Other Key Related Reports
1. Executive Summary |
2. Introduction |
2.1 Report Description |
2.2 Key Highlights of The Report |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3. Global Hydroxychloroquine and Chloroquine Market Overview |
3.1 Global Country Indicators |
3.2 Global Hydroxychloroquine and Chloroquine Market Revenues 2016-2026F |
3.3 Global Hydroxychloroquine and Chloroquine Market Revenue Share, By Type, 2019 & 2026F |
3.4 Global Hydroxychloroquine and Chloroquine Market Revenue Share, By Route of Administration, 2019 & 2026F |
3.5 Global Hydroxychloroquine and Chloroquine Market Revenue Share, By Dosage, 2019 & 2026F |
3.6 Global Hydroxychloroquine and Chloroquine Market Revenue Share, By Applications, 2019 & 2026F |
3.7 Global Hydroxychloroquine and Chloroquine Market - Industry Life Cycle |
3.8 Global Hydroxychloroquine and Chloroquine Market - Porter’s Five Forces |
4. Global Hydroxychloroquine and Chloroquine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5. Global Hydroxychloroquine and Chloroquine Market Trends |
6. Global Hydroxychloroquine and Chloroquine Market Overview, By Type |
6.1 Global Hydroxychloroquine and Chloroquine Market Revenues, By Injectable Dosage,2016-2026F |
6.2 Global Hydroxychloroquine and Chloroquine Market Revenues, By Tablet, 2016-2026F |
7. Global Hydroxychloroquine and Chloroquine Market Overview, By Route of Administration |
7.1 Global Hydroxychloroquine and Chloroquine Market Revenues, By Oral, 2016-2026F |
7.2 Global Hydroxychloroquine and Chloroquine Market Revenues, By Intravenous, 2016-2026F |
8. Global Hydroxychloroquine and Chloroquine Market Overview, By Dosage |
8.1 Global Hydroxychloroquine and Chloroquine Market Revenues, By 100 MG, 2016-2026F |
8.2 Global Hydroxychloroquine and Chloroquine Market Revenues, By 200 MG, 2016-2026F |
8.3 Global Hydroxychloroquine and Chloroquine Market Revenues, By 250 MG, 2016-2026F |
8.4 Global Hydroxychloroquine and Chloroquine Market Revenues, By 500 MG, 2016-2026F |
9. Global Hydroxychloroquine and Chloroquine Market Overview, By Applications |
9.1 Global Hydroxychloroquine and Chloroquine Market Revenues, By COVID-19, 2016-2026F |
9.2 Global Hydroxychloroquine and Chloroquine Market Revenues, By Rheumatoid Arthritis, 2016-2026F |
9.3 Global Hydroxychloroquine and Chloroquine Market Revenues, By Malaria, 2016-2026F |
9.4 Global Hydroxychloroquine and Chloroquine Market Revenues, By Others, 2016-2026F |
10. North America Hydroxychloroquine and Chloroquine Market Overview |
10.1 North America Hydroxychloroquine and Chloroquine Market Revenues, 2016-2026F |
10.2 North America Hydroxychloroquine and Chloroquine Market Revenues, By Type, 2016-2026F |
10.3 North America Hydroxychloroquine and Chloroquine Market Revenues, By Route Administration, 2016-2026F |
10.4 North America Hydroxychloroquine and Chloroquine Market Revenues, By Dosage, 2016-2026F |
10.5 North America Hydroxychloroquine and Chloroquine Market Revenues, By Applications, 2016-2026F |
11. Latin America Hydroxychloroquine and Chloroquine Market Overview |
11.1 Latin America Hydroxychloroquine and Chloroquine Market Revenues, 2016-2026F |
11.2 Latin America Hydroxychloroquine and Chloroquine Market Revenues, By Type, 2016-2026F |
11.3 Latin America Hydroxychloroquine and Chloroquine Market Revenues, By Route Administration, 2016-2026F |
11.4 Latin America Hydroxychloroquine and Chloroquine Market Revenues, By Dosage, 2016-2026F |
11.5 Latin America Hydroxychloroquine and Chloroquine Market Revenues, By Applications, 2016-2026F |
12. Asia Pacific Hydroxychloroquine and Chloroquine Market Overview |
12.1 Asia Pacific Hydroxychloroquine and Chloroquine Market Revenues, 2016-2026F |
12.2 the Asia Pacific Hydroxychloroquine and Chloroquine Market Revenues, By Type, 2016-2026F |
12.3 the Asia Pacific Hydroxychloroquine and Chloroquine Market Revenues, By Route Administration, 2016-2026F |
12.4 the Asia Pacific Hydroxychloroquine and Chloroquine Market Revenues, By Dosage, 2016-2026F |
12.5 the Asia Pacific Hydroxychloroquine and Chloroquine Market Revenues, By Applications, 2016-2026F |
13. Europe Hydroxychloroquine and Chloroquine Market Overview |
13.1 Europe Hydroxychloroquine and Chloroquine Market Revenues, 2016-2026F |
13.2 Europe Hydroxychloroquine and Chloroquine Market Revenues, By Type, 2016-2026F |
13.3 Europe Hydroxychloroquine and Chloroquine Market Revenues, By Route Administration, 2016-2026F |
13.4 Europe Hydroxychloroquine and Chloroquine Market Revenues, By Dosage, 2016-2026F |
13.5 Europe Hydroxychloroquine and Chloroquine Market Revenues, By Applications, 2016-2026F |
14. The Middle East and Africa Hydroxychloroquine and Chloroquine Market Overview |
14.1 the Middle East Hydroxychloroquine and Chloroquine Market Revenues, 2016-2026F |
14.2 the Middle East Hydroxychloroquine and Chloroquine Market Revenues, By Type, 2016-2026F |
14.3 the Middle East Hydroxychloroquine and Chloroquine Market Revenues, By Route Administration, 2016-2026F |
14.4 the Middle East Hydroxychloroquine and Chloroquine Market Revenues, By Dosage, 2016-2026F |
14.5 the Middle East Hydroxychloroquine and Chloroquine Market Revenues, By Applications, 2016-2026F |
14. Global Hydroxychloroquine and Chloroquine Market - Key Performance Indicators |
15. Global Hydroxychloroquine and Chloroquine Market - Opportunity Assessment |
15.1 Global Hydroxychloroquine and Chloroquine Market Opportunity Assessment, By Type, 2026F |
15.2 Global Hydroxychloroquine and Chloroquine Market Opportunity Assessment, By Route of Administration, 2026F |
15.3 Global Hydroxychloroquine and Chloroquine Market Opportunity Assessment, By Dosage, 2026F |
15.4 Global Hydroxychloroquine and Chloroquine Market Opportunity Assessment, By Applications, 2026F |
18. Global Hydroxychloroquine and Chloroquine Market Competitive Landscape |
18.1 Global Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.1.1 North America Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.1.2 Latin America Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.1.3 Asia Pacific Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.1.4 Europe Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.1.5 the Middle East and Africa Hydroxychloroquine and Chloroquine Market Revenue Share, By Companies, 2019 |
18.2 Global Hydroxychloroquine and Chloroquine Market Competitive Benchmarking, By Operating Parameters |
19. Company Profiles |
20. Key Recommendations |
21. Disclaimer |